Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001897612-25-000055·IONIS PHARMACEUTICALS INC
Schedule 13G ownership disclosure
IONIS PHARMACEUTICALS INC
COMMON STOCK · CUSIP: 462222100
Event date: 2025-01-31
- Filing-level shares
- 15,851,863
- Percent of class
- 10.0%
- T. Rowe Price Investment Management, Inc.
Shares: 15,851,863 · Class: 10.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001897612-25-000055
- Form type
- SCHEDULE 13G/A
- Filer
- IONIS PHARMACEUTICALS INC
- CIK
- CIK 874015
- Filed
- Feb 07, 2025
- Reporting period
- Jan 31, 2025
- Description
- Schedule 13G beneficial ownership